Phio Announces Key PH-762 Milestone with FDA Submission for Next Stage of Cutaneous Squamous Cell Carcino - Benzinga

Source: Benzinga · 2026-09-14T21:45:19+00:00

Phio Announces Key PH-762 Milestone with FDA Submission for Next Stage of Cutaneous Squamous Cell Carcino Benzinga

BestAIBroker analysis

Finance-aware sentiment: slightly positive (+0.30 on a -1 to +1 scale).
Event classification: PARTNERSHIP.
Market importance score: 38/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.
Symbols referenced: PH, PHIO.